Clinical trial

Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy

NCT04674254

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-30

PhasePHASE4

Study timeline

Study start (actual)2021-03-30Date precision: day

Registry last updated2024-01-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Proliferative Diabetic Retinopathyunresolved

Vascular Endothelial Growth Factor Overexpressionunresolved

Diabetic Retinopathyunresolved

Interventions

Bevacizumab InjectionDRUG · verified · RxNorm: bevacizumab Injection

Targeted retinal photocoagulationPROCEDURE

Standard pan-retinal photocoagulationPROCEDURE

Sponsors & collaborators

Cairo Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04674254 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.